These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27154548)

  • 1. Temporal trends in the utilization of vasopressors in intensive care units: an epidemiologic study.
    Thongprayoon C; Cheungpasitporn W; Harrison AM; Carrera P; Srivali N; Kittamongkolchai W; Erdogan A; Kashani KB
    BMC Pharmacol Toxicol; 2016 May; 17(1):19. PubMed ID: 27154548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the use of renal replacement therapy modality in intensive care unit: a 7 year study.
    Thongprayoon C; Cheungpasitporn W; Ahmed AH
    Ren Fail; 2015; 37(9):1444-7. PubMed ID: 26337852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressor Therapy in the Intensive Care Unit.
    Russell JA; Gordon AC; Williams MD; Boyd JH; Walley KR; Kissoon N
    Semin Respir Crit Care Med; 2021 Feb; 42(1):59-77. PubMed ID: 32820475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.
    Levine AR; Meyer MJ; Bittner EA; Berg S; Kalman R; Stanislaus AB; Ryan C; Ball SA; Eikermann M
    J Crit Care; 2013 Oct; 28(5):756-62. PubMed ID: 23845791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Vasopressor Utilization Strategies and Outcomes in Critically Ill Patients With Severe Traumatic Brain Injury.
    Toro C; Ohnuma T; Komisarow J; Vavilala MS; Laskowitz DT; James ML; Mathew JP; Hernandez AF; Goldstein BA; Sampson JH; Krishnamoorthy V
    Anesth Analg; 2022 Dec; 135(6):1245-1252. PubMed ID: 35203085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressor dose equivalence: A scoping review and suggested formula.
    Goradia S; Sardaneh AA; Narayan SW; Penm J; Patanwala AE
    J Crit Care; 2021 Feb; 61():233-240. PubMed ID: 33220576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasopressors in Sepsis.
    Colling KP; Banton KL; Beilman GJ
    Surg Infect (Larchmt); 2018; 19(2):202-207. PubMed ID: 29336676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Use of Midodrine in the ICU: A Single-Center Retrospective Case Series.
    Rizvi MS; Trivedi V; Nasim F; Lin E; Kashyap R; Andrijasevic N; Gajic O
    Crit Care Med; 2018 Jul; 46(7):e628-e633. PubMed ID: 29613861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressors and development of pressure ulcers in adult critical care patients.
    Cox J; Roche S
    Am J Crit Care; 2015 Nov; 24(6):501-10. PubMed ID: 26523008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
    Bauer SR; Lam SW; Cha SS; Oyen LJ
    J Crit Care; 2008 Dec; 23(4):500-6. PubMed ID: 19056013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing use of less-invasive hemodynamic monitoring in 3 specialty surgical intensive care units: a 5-year experience at a tertiary medical center.
    Kirton OC; Calabrese RC; Staff I
    J Intensive Care Med; 2015 Jan; 30(1):30-6. PubMed ID: 23940109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between early vasopressor administration and in-hospital mortality in critically ill patients with acute pancreatitis: A cohort study from the MIMIC-IV database.
    Shi H; Sun SY; He YS; Peng Q
    Eur Rev Med Pharmacol Sci; 2023 Jan; 27(2):787-798. PubMed ID: 36734720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early vasopressor use in critical injury is associated with mortality independent from volume status.
    Plurad DS; Talving P; Lam L; Inaba K; Green D; Demetriades D
    J Trauma; 2011 Sep; 71(3):565-70; discussion 570-2. PubMed ID: 21908995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical care management of verapamil and diltiazem overdose with a focus on vasopressors: a 25-year experience at a single center.
    Levine M; Curry SC; Padilla-Jones A; Ruha AM
    Ann Emerg Med; 2013 Sep; 62(3):252-8. PubMed ID: 23642908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trends and Clinical Outcomes Associated with Vasopressor and Inotrope Use in The Cardiac Intensive Care Unit.
    Jentzer JC; Wiley B; Bennett C; Murphree DH; Keegan MT; Kashani KB; Bell MR; Barsness GW
    Shock; 2020 Apr; 53(4):452-459. PubMed ID: 31169766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressors for shock.
    Müllner M; Urbanek B; Havel C; Losert H; Waechter F; Gamper G
    Cochrane Database Syst Rev; 2004; (3):CD003709. PubMed ID: 15266497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Mortality in Patients Treated With Phenylephrine in Septic Shock.
    Patel VV; Sullivan JB; Cavanaugh J
    J Pharm Pract; 2023 Feb; 36(1):15-18. PubMed ID: 33752492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National growth in intensive care unit admissions from emergency departments in the United States from 2002 to 2009.
    Mullins PM; Goyal M; Pines JM
    Acad Emerg Med; 2013 May; 20(5):479-86. PubMed ID: 23672362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.